Dr Sheth also spoke about staffing gaps at NMC, action taken against medical colleges for non-compliance, MBBS fee regulation, and the rollout of the National Exit Test (NExT).

An FDA risk review has cleared the way for canine freeze-dried plasma, a shelf-stable product that could expand transfusion options in emergencies. A freeze-dried plasma product for canine patients is ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six months in BCG-Unresponsive patients Company expects ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. International guidelines for treatment of children with severe acute malnutrition advise against giving ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of its supplemental Biologics License ...

Whether you're a still, sparkling or tap water fan. the chances are that you're not as hydrated as you think you are.

According to the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, patients with heart failure are classified into: heart failure with reduced ejection fraction (HFrEF, LVEF ...

Welcome to the ME 270 course website for the Spring 2026 term. The material on this site is a complement to the lecture book for the course. And, all material here is accessible without the need to ...

Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026Initiated global Phase 3 LEVEL-2 ...

A growing body of neuroimaging research is pinpointing exactly how psychedelic drugs hijack the brain’s visual system to ...

LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported ...